Showing posts with label breast cancer awareness month. Show all posts
Showing posts with label breast cancer awareness month. Show all posts

Thursday, October 25, 2018

The Pink Ribbon should have a Blue Streak: Male Breast Cancer


October is breast cancer awareness month, which is an annual campaign to increase the awareness about the deadly disease. I am sharing a series of articles on breast cancer this month. There is a common belief that breast cancer only occurs in women, but contrary to the popular belief breast cancer does occur in men. 

Male Breast Cancer is a very informative article authored by Dr. Avinash Deo, M.D., from his Health and Wellness website All About CancerDr. Deo is a Medical Oncologist and Haematologist, Medical Blogger and Medical Writer based at Mumbai, Mumbai, Maharashtra, India.

Male Breast Cancer
The pink ribbon is for breast cancer because pink is for women. Some of the breast cancers are not pink. They are blue. About 0.5-1% of the breast cancer patients are men. In Africa as many as 6% of the breast cancer patients are men. This is about a ribbon pink to the world, blue from inside.

What Causes Breast Cancer in Men?
The risk of breast cancer increase with age. Men develop breast cancer at an older age than women. On an average, a patient with a male breast cancer is 5 years older than a female patient with breast cancer. Male breast cancer is more common in blacks.

Male relatives of female breast cancer have a higher risk of breast cancer. The risk is doubled if a first degree (immediate) relative has suffered from breast cancer. One of the reasons for this is BRCA gene mutations. BRCA genes are involved in repair of DNA. There are two BRCA genes. The lifetime risk of breast cancer in men with BRCA2 gene mutations is about 5-15% and for BRCA1 gene mutations is up to 4%. This is opposite that seen in women. Women with BRCA1 mutations have a higher risk of breast cancer than those with BRCA2 mutations.

Conditions associated with an increase in the female hormone, estrogen, increased the risk of breast cancer. The conditions include

Klinefelter’s syndrome: Klinefelter’s syndrome, a disease where the patient has one extra X chromosome, increases the risk of breast cancer 50 times.
Liver Disease: Patients with a chronic liver disease have increased levels of estrogens and an increased risk of breast cancer.
Other Diseases: Obesity and testicular dysfunction may increase the risk of male breast cancer.
Exposure to radiation increases the risk of male breast cancer.

What Are The Symptoms of Male Breast Cancer?
The symptoms of male breast cancer include:

Lump in the breast
Ullcer or deformity of the nipple
Lump in the armpit
Rarely there may be swelling of the arm


Diagnosis of Breast Cancer In Men?
The diagnosis of breast cancer is made by a biopsy of the lump. Almost all males with breast cancer have cancers that have oestrogen receptors. This means that these cancers depend on the female hormone oestrogen for growth. This is a paradox as more breast cancers in men than in women depend on female hormones. Only 80% of the breast cancers occurring in women depend on female hormones for growth. Breast cancer in women can be diagnosed early by mammography. Mammography is not useful in men.

How is Male Breast Cancer Treated?
Male breast cancer is treated like female breast cancer with surgery followed by chemotherapy and/or radiation. There are however a few differences.

Male breast cancer patients have a more advanced cancer. Many need radiation and chemotherapy.

Almost all breast cancers in men depend on oestrogens for growth. They need to be treated with hormonal drugs that deprive the cancer of oestrogens. Tamoxifen is such a drug. Another category of drugs that deprive a cancer of oestrogen is aromatase inhibitors. It is not certain is they are as active in men as in women. Tamoxifen can cause nausea, headaches, fatigue, hot flashes, skin rash, sexual dysfunction, mood changes an and weight gain.
Men with breast cancer may carry a BRCA mutation, that is also likely to affect other members of the family. Women with BRCA mutations are at a very high risk of breast and ovarian cancer. Men with breast cancer should be tested for BRCA mutations. If a mutation is detected blood relatives should also be tested.

Is Male Breast Cancer More Dangerous?
Male breast cancer is perceived to be more dangerous than female breast cancer. In reality, males and females have comparable cure rates if they are diagnosed at the same stage. Lack of awareness about male breast cancer results in a delay in both men consulting a physician and the physician ordering the appropriate investigations. The delay results in a diagnosis at a more advanced stage and makes the disease more difficult to control.

Men with breast cancer are older than women with breast cancer. Age-related diseases like cardiac diseases that are more common in men come in the way of giving the complete treatment. This reduces the cure rate.



The Pink Ribbon Should Have A Blue Streak!

Should the pink ribbon have a blue streak? Probably yes. To remind us that about one percent of patients with breast cancer are men. To remind men not to ignore a lump under the nipple. Men who are diagnosed late because of lack of awareness about the male breast cancer. Men who have to deal with the psychological consequences of suffering a “woman’s disease”.

Sunday, October 14, 2018

Weight loss decreases breast cancer risk in postmenopausal women


October is breast cancer awareness month, which an annual campaign to increase the awareness about the deadly disease. With over 2 million new cases every year, it is the most prevalent cancer in women. Although breast cancer runs in families, there are other lifestyle and environmental factors which increase the risk of breast cancer.

Obesity increases the risk of postmenopausal breast cancer; the risk is 1.5 times higher in overweight women and about 2 times in obese women than healthy weight women. The association between weight loss and incidence of breast cancer is inconsistent, and few studies have evaluated the association between the two.

 A recent observational study by Chlebowski RT et al. published in Cancer, the peer-reviewed journal of the American Cancer Society reported that women decreased the risk of breast cancer by 12% if they lost weight in 3 years as compared to the ones whose weight remained stable.

“Obesity is associated with increased risk of incident postmenopausal breast cancer,” Rowan T. Chlebowski, MD, Ph.D., research professor in the department of medical oncology and therapeutics research at City of Hope National Medical Center, and colleagues wrote. “Because approximately one-third of postmenopausal women in the United States are obese, obesity represents a common and potentially modifiable factor related to breast cancer outcome. However, it has not been established that weight loss in postmenopausal women decreases breast cancer incidence or breast cancer mortality.”

The researchers from the Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California used data from the Women’s Health Initiative (WHI) Observational Study to study the association.

The study included 61,335 postmenopausal women with no prior history of breast cancer and normal mammogram with body weight and height measured and body mass index (BMI) calculated at baseline and after 3 years.

At the end of 3 years, the analysis was based on 3 weight categories: stable, 5% increase or 5% decrease.

The study participants were between 50 to 79 years, and the mean follow-up duration was 11.4 years, during which the researchers observed 3,061 cases of breast cancer.

Women (n = 8175) who lost weight faced a 12% decreased risk of breast cancer as compared to women whose weight remained stable (n = 41,139) (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.78‐0.98; P = .02). The association remained the same even after adjustment for mammography.

The mean time to develop breast cancer was 6.5 years after the 3-year weight determination.

Women who gained (≥5%) weight (n = 12,021) were not associated with increased risk of breast cancer (HR, 1.02; 95% CI, 0.93‐1.11) but did show a slightly higher incidence of triple‐negative breast cancer (HR, 1.54; 95% CI, 1.16‐2.05).

“Our study indicates that moderate, relatively short-term weight reduction was associated with a statistically significant reduction in breast cancer risk for postmenopausal women,” said Dr. Chlebowski in Wiley press release. “These are observational results, but they are also supported by randomized clinical trial evidence from the Women's Health Initiative Dietary Modification trial where, in a randomized clinical trial setting, adopting a low-fat dietary pattern that was associated with a similar magnitude of weight loss resulted in a significant improvement in breast cancer overall survival. These findings, taken together, provide strong correlative evidence that a modest weight loss program can impact breast cancer.”

Here is the visual abstract of the study.



Thursday, October 5, 2017

Latest facts and figures about Breast Cancer from American Cancer Society


October is breast cancer awareness month. Here are some facts and figures to know from American Cancer Society (ACS).

Increasing awareness among women, increased screening and better techniques for early cancer detection has decreased a woman’s risk of dying from breast cancer by 38% between late 1980s and 2014, translating into 297,300 fewer cancer death during that period.

However, much is needed to be done as breast cancer is still second leading cause of cancer death in women, being exceeded by lung cancer which kills more women peryear.

A woman chances of dying from breast cancer is about 1 in 37 (about 2.7 percent).

ACS estimates for breast cancer for the year 2017 are:

Currently, there are more than 3.1 million people with breast cancer in USA, which includes persons undergoing treatment and also persons who have already completed the treatment.

It is expected that about 40,610 women will die from breast cancer in the year 2017.

About 63,410 new cases of carcinoma in situ (CIS) and 252,710 new cases of invasive breast cancer will be diagnosed in 2017

Although the incidence of breast cancer is nearly same in black and white women, black women are more likely to die from breast cancer.

Some latest research related to risk factors shows that:

Long term and heavy smoking increases a woman’s risk of breast cancer particularly if it started before her first pregnancy.

An obese postmenopausal woman faces 1.5 times increased risk of cancer, if she is overweight and 2 times the risk if she is obese women as compared to lean women.

Evidence is accumulating that regular physically activity lower your chances of breast cancer by 10-25%, more so in postmenopausal than premenopausal women.

Each alcoholic drink/day increases the chances of getting breast cancer by 7-10% on an average and women who regularly consume 2-3 drinks have 20% higher chances as compared to non-drinkers.